Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
25 Jul 2019, 09:00
Second-generation Live Biotherapeutic Identified and Mechanistic Data on MRx0518 and MRx1299…
8 Jul 2019, 09:00
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics,…
6 Jun 2019, 10:00
4D pharma plc (AIM: DDDD) today announced that data from the completed Phase Ib clinical study of…
3 Jun 2019, 09:00
4D pharma plc announces the presentation of a poster detailing its Phase I/II clinical study of…
16 May 2019, 09:00
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of Live…
13 May 2019, 08:00
4D’s Research and Development team is giving a poster presentation on preclinical data from the…
2 May 2019, 09:00
4D pharma will present preclinical data on its neurodegenerative disorders programme targeting…
29 Apr 2019, 09:00
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics,…
8 Mar 2019, 09:00
4D announces participation in Chardan’s Inaugural Microbiome Medicines Summit, USA
29 Jan 2019, 09:00
4D pharma announces publication of data highlighting immuno-stimulatory properties of MRx0518
8 Jan 2019, 09:00
4D pharma plc announces the appointment of Ed Baracchini, PhD, and Professor Axel Glasmacher, MD, as…
7 Jan 2019, 09:00
4D pharma plc (AIM: DDDD) and The University of Texas MD Anderson Cancer Center today announced a…
8 Nov 2018, 12:00
4D pharma plc announces first patient enrolment in Blautix IBS Phase II study
24 Sep 2018, 12:00
4D pharma plc (AIM: DDDD), announces positive top-line results for its Phase Ib study of Thetanix in…
14 Aug 2018, 09:00
Data suggests that MRx0004 is a promising next-generation therapeutic for management of asthma
